{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:16:36Z","timestamp":1792196196599,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T00:00:00Z","timestamp":1514332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41397-017-0003-3","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T17:57:02Z","timestamp":1514397422000},"page":"704-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"18","author":[{"given":"\u00c1ngela","family":"Gutierrez-Camino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitane","family":"Umerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Martin-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagore","family":"Garc\u00eda de Andoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizpea","family":"Echebarria-Barona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Navajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-3080","authenticated-orcid":false,"given":"Africa","family":"Garcia-Orad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.canep.2010.06.020","volume":"34","author":"WT Johnston","year":"2010","unstructured":"Johnston WT, Lightfoot TJ, Simpson J, Roman E. Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 2010;34:659\u201366.","journal-title":"Cancer Epidemiol"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","volume":"596","author":"VA Carozzi","year":"2015","unstructured":"Carozzi VA, Canta A, Chiorazzi A. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? Neurosci Lett 2015;596:90\u2013107.","journal-title":"Neurosci Lett"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/FPC.0000000000000191","volume":"26","author":"A Gutierrez-Camino","year":"2016","unstructured":"Gutierrez-Camino A, Martin-Guerrero I, Lopez-Lopez E, Echebarria-Barona A, Zabalza I, Ruiz I, et al Lack of association of the CEP72rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population. Pharm Genom 2016;26:100\u20132.","journal-title":"Pharm Genom"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/pgs.14.68","volume":"15","author":"F Ceppi","year":"2014","unstructured":"Ceppi F, Langlois-Pelletier C, Gagne V, Rousseau J, Ciolino C, De Lorenzo S, et al Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia. Pharmacogenomics 2014;15:1105\u201316.","journal-title":"Pharmacogenomics"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01050259","volume":"15","author":"TJ Postma","year":"1993","unstructured":"Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ. Long-term effects of vincristine on the peripheral nervous system. J Neurooncol 1993;15:23\u201327.","journal-title":"J Neurooncol"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/pgs-2016-0001","volume":"17","author":"E Lopez-Lopez","year":"2016","unstructured":"Lopez-Lopez E, Gutierrez-Camino A, Astigarraga I, Navajas A, Echebarria-Barona A, Garcia-Miguel P, et al Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia. Pharmacogenomics 2016;17:731\u201341.","journal-title":"Pharmacogenomics"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2015.0894","volume":"313","author":"B Diouf","year":"2015","unstructured":"Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, et al Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 2015;313:815\u201323.","journal-title":"JAMA"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.leukres.2009.04.027","volume":"34","author":"A Hartman","year":"2010","unstructured":"Hartman A, van Schaik RHN, van der Heiden IP, Broekhuis MJC, Meier M, den Boer ML, et al Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia. Leuk Res 2010;34:154\u20139.","journal-title":"Leuk Res"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1440-1754.2011.02103.x","volume":"47","author":"AS Moore","year":"2011","unstructured":"Moore AS, Norris R, Price G, Nguyen T, Ni M, George R, et al Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach. J Paediatr Child Health 2011;47:875\u201382.","journal-title":"J Paediatr Child Health"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22845","volume":"56","author":"A Egbelakin","year":"2011","unstructured":"Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, Quinney SK, et al Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2011;56: 361\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clpt.2004.05.007","volume":"76","author":"SLA Plasschaert","year":"2004","unstructured":"Plasschaert SLA, Groninger E, Boezen M, Kema I, de Vries EGE, Uges D, et al Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia. Clin Pharmacol Ther 2004;76:220\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pharmthera.2011.04.009","volume":"131","author":"M Nakajima","year":"2011","unstructured":"Nakajima M, Yokoi T. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacol Ther 2011;131:330\u20137.","journal-title":"Pharmacol Ther"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"pii:E1096","DOI":"10.3390\/ijerph13111096","volume":"13","author":"MP Li","year":"2016","unstructured":"Li M-P, Hu Y-D, Hu X-L, Zhang Y-J, Yang Y-L, Jiang C, et al MiRNAs and miRNA polymorphisms modify drug response. Int J Environ Res Pub Health 2016;13:pii:E1096 \n                        https:\/\/doi.org\/10.3390\/ijerph13111096","journal-title":"Int J Environ Res Pub Health"},{"key":"3_CR14","doi-asserted-by":"crossref","unstructured":"Gutierrez-Camino A, Oosterom N, den Hoed MAH, Lopez-Lopez E, Martin-Guerrero I, Pluijm SMF et al. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia. Pharmacogenet Genome 2017;27:303\u20136.","DOI":"10.1097\/FPC.0000000000000291"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2217\/pgs.14.106","volume":"15","author":"E Lopez-Lopez","year":"2014","unstructured":"Lopez-Lopez E, Gutierrez-Camino A, Bilbao-Aldaiturriaga N, Pombar-Gomez M, Martin-Guerrero I, Garcia-Orad A. Pharmacogenetics of childhood acute lymphoblastic leukemia. Pharmacogenomics 2014;15:1383\u201398.","journal-title":"Pharmacogenomics"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/FPC.0000000000000245","volume":"26","author":"L Iparraguirre","year":"2016","unstructured":"Iparraguirre L, Gutierrez-Camino A, Umerez M, Martin-Guerrero I, Astigarraga I, Navajas A, et al MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. Pharm Genom 2016;26:517\u201325.","journal-title":"Pharm Genom"},{"key":"3_CR17","volume-title":"Molecular cloning: a laboratory manual.","author":"JRD Sambrook","year":"2001","unstructured":"Sambrook JRD. Molecular cloning: a laboratory manual. 3rd edn. New York: NY: Cold Spring Harbor Laboratory Press; 2001.","edition":"3rd edn."},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279\u201384.","journal-title":"Behav Brain Res"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/003335490912400320","volume":"124","author":"KM Sullivan","year":"2009","unstructured":"Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep 2009;124:471\u20134.","journal-title":"Public Health Rep"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"W70","DOI":"10.1093\/nar\/gkn188","volume":"36","author":"AR Gruber","year":"2008","unstructured":"Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 2008;36:W70\u20134.","journal-title":"Nucleic Acids Res"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA binding sites by \u2018walking\u2019 the genes of three genomes. J Biomed Inform 2011;44:839\u201347.","journal-title":"J Biomed Inform"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.1093\/nar\/gks1055","volume":"41","author":"A Kamburov","year":"2013","unstructured":"Kamburov A, Stelzl U, Lehrach H, Herwig R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res 2013;41:D793\u2013800.","journal-title":"Nucleic Acids Res"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017;45:D353\u2013D361.","journal-title":"Nucleic Acids Res"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","volume":"44","author":"A Fabregat","year":"2016","unstructured":"Fabregat A, Sidiropoulos K, Garapati P, Gillespie M, Hausmann K, Haw R, et al The Reactome pathway Knowledgebase. Nucleic Acids Res 2016;44:D481\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03602532.2014.901348","volume":"46","author":"T Kunicka","year":"2014","unstructured":"Kunicka T, Soucek P. Importance of ABCC1 for cancer therapy and prognosis. Drug Metab Rev 2014;46:325\u201342.","journal-title":"Drug Metab Rev"},{"key":"3_CR26","first-page":"4","volume":"17","author":"R Franca","year":"2017","unstructured":"Franca R, Rebora P, Bertorello N, Fagioli F, Conter V, Biondi A, et al Pharmacogenetics and induction\/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol. Pharm J 2017;17:4\u201310.","journal-title":"Pharm J"},{"key":"3_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-6-61","volume":"6","author":"S Awasthi","year":"2005","unstructured":"Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, et al RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 2005;6:61.","journal-title":"BMC Neurosci"},{"key":"3_CR28","first-page":"139","volume":"30","author":"KJ Drake","year":"2007","unstructured":"Drake KJ, Singhal J, Yadav S, Nadkar A, Pungaliya C, Singhal SS, et al RALBP1\/RLIP76 mediates multidrug resistance. Int J Oncol 2007;30:139\u201344.","journal-title":"Int J Oncol"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/humu.21641","volume":"33","author":"J Gong","year":"2012","unstructured":"Gong J, Tong Y, Zhang H-M, Wang K, Hu T, Shan G, et al Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 2012;33:254\u201363.","journal-title":"Hum Mutat"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2015.06.001","volume":"131","author":"V Chiono","year":"2015","unstructured":"Chiono V, Tonda-Turo C. Trends in the design of nerve guidance channels in peripheral nerve tissue engineering. Prog Neurobiol 2015;131:87\u2013104.","journal-title":"Prog Neurobiol"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ddr.21278","volume":"76","author":"YJD Lee","year":"2015","unstructured":"Lee YJD, Kim V, Muth DC, Witwer KW. Validated MicroRNA Target Databases: An Evaluation. Drug Dev Res 2015;76:389\u201396.","journal-title":"Drug Dev Res"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/nar\/gkv1221","volume":"44","author":"MM Akhtar","year":"2016","unstructured":"Akhtar MM, Micolucci L, Islam MS, Olivieri F, Procopio AD. Bioinformatic tools for microRNA dissection. Nucleic Acids Res 2016;44:24\u201344.","journal-title":"Nucleic Acids Res"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41397-017-0003-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-017-0003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-017-0003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:59:03Z","timestamp":1684616343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-017-0003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1038\/s41397-017-0003-3","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]}}}